Drugs / [11C]PF-06809247
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03100136 | Nov 2016 → Mar 2017 | neuritis | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]PF-06809247 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03100136 ↗ |
| Modality | Diagnostic / imaging agent | “Positron Emission Tomography (PET) tracer” NCT03100136 ↗ |
| Route | Intravenous | “intravenous injection” NCT03100136 ↗ |